FDA Inspection 1277864 — Long Grove Pharmaceuticals LLC
The FDA completed an inspection of Long Grove Pharmaceuticals LLC on Jul 9, 2025 in Rosemont, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 9, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rosemont, IL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)